XP0022092207, E.D. Dzoljic, “Effect of Ibogaine on Naloxone-Precipitated Withdrawal Syndrome in Chronic Morphine-Dependent Rats”, vol. 294, 1988, pp. 64-70 (Abstract). |
XP002090228, Piotr Popik, “Inhibition of Reinforcing Effects of Morphine and Motivational Aspects of Naloxone-Precipitated Opiod Withdrawal by N-Methyl-D-Aspartate Receptor Antagonist, Memantine”, vol. 280, 1997, pp. 854-865 (Abstract). |
XP002092209, Susanne Capendijk, “The Inhibitory Effect of Norharman on Morphine Withdrawal Syndrome in Rats: Comparison with Ibogaine”, vol. 65, 1994, pp. 117-119 (Abstract). |
XP002092210, S.D. Glick et al., “Effects of Ibogaine on Acute Signs of Morphine Withdrawal in Rats Independence from Tremor”, vol. 31, 1992, pp. 457-500 (Abstract). |
XP002092211, M. Soyka, “Efficacy of Acamprostate in the Relapse Prevention of Alcohol Dependence. Results of Clinical TraiLs and Therapeutical Prospects”, 1995, pp. 83-86 (Abstract). |
Drugs and Therapy Prospectives, 10/5 (1-5) (1997) (abstract).* |
Besson, J., Schweizerische Medizinische Wochenschrift, 127/38, pp. 1574-1578 (1997) (abstract). |